Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population

E. Pajkrt, B. W J Mol, J. M M Van Lith, O. P. Bleker, C. M. Bilardo

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective. To examine the discriminative capacity of nuchal translucency measurement in the detection of trisomy 21 and other chromosomal anomalies. Design. Prospective cohort study. Subjects. A total of 2247 women with viable singleton pregnancies between 10 and 14 weeks' gestation attending a prenatal diagnosis center for fetal karyotyping. Methods. The fetal nuchal translucency was measured transabdominally in all women before invasive prenatal testing. Results. Chromosomal abnormalities were found in 63 fetuses, including 36 with Down's syndrome. The likelihood of the presence of chromosomal abnormalities increased with larger nuchal translucency thickness. A nuchal translucency of 3 mm or more identified 25 out of 36 fetuses (69%) with trisomy 21 at the expense of a 4.0% false-positive rate. Correction of nuchal translucency measurements for differences due to variation of the measurement with gestational age, either by using the 'delta-value' or multiples of the median (MoM), did not improve the detection rate in our patient data set. Conclusions. The discriminative capacity of nuchal translucency measurement makes is a useful tool in screening for trisomy 21 and other chromosomal anomalies.

LanguageEnglish
Pages156-162
Number of pages7
JournalUltrasound in Obstetrics and Gynecology
Volume12
Issue number3
DOIs
Publication statusPublished - 28 Oct 1998

Keywords

  • Down's syndrome
  • Fetal aneuploidies
  • Nuchal translucency
  • Prenatal diagnosis
  • Ultrasound screening

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Reproductive Medicine
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynaecology

Cite this

Pajkrt, E. ; Mol, B. W J ; Van Lith, J. M M ; Bleker, O. P. ; Bilardo, C. M. / Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population. In: Ultrasound in Obstetrics and Gynecology. 1998 ; Vol. 12, No. 3. pp. 156-162.
@article{de95e3522a5d43f1997bdc9b2945588d,
title = "Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population",
abstract = "Objective. To examine the discriminative capacity of nuchal translucency measurement in the detection of trisomy 21 and other chromosomal anomalies. Design. Prospective cohort study. Subjects. A total of 2247 women with viable singleton pregnancies between 10 and 14 weeks' gestation attending a prenatal diagnosis center for fetal karyotyping. Methods. The fetal nuchal translucency was measured transabdominally in all women before invasive prenatal testing. Results. Chromosomal abnormalities were found in 63 fetuses, including 36 with Down's syndrome. The likelihood of the presence of chromosomal abnormalities increased with larger nuchal translucency thickness. A nuchal translucency of 3 mm or more identified 25 out of 36 fetuses (69{\%}) with trisomy 21 at the expense of a 4.0{\%} false-positive rate. Correction of nuchal translucency measurements for differences due to variation of the measurement with gestational age, either by using the 'delta-value' or multiples of the median (MoM), did not improve the detection rate in our patient data set. Conclusions. The discriminative capacity of nuchal translucency measurement makes is a useful tool in screening for trisomy 21 and other chromosomal anomalies.",
keywords = "Down's syndrome, Fetal aneuploidies, Nuchal translucency, Prenatal diagnosis, Ultrasound screening",
author = "E. Pajkrt and Mol, {B. W J} and {Van Lith}, {J. M M} and Bleker, {O. P.} and Bilardo, {C. M.}",
year = "1998",
month = "10",
day = "28",
doi = "10.1046/j.1469-0705.1998.12030156.x",
language = "English",
volume = "12",
pages = "156--162",
journal = "Ultrasound in Obstetrics and Gynecology",
issn = "0960-7692",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population. / Pajkrt, E.; Mol, B. W J; Van Lith, J. M M; Bleker, O. P.; Bilardo, C. M.

In: Ultrasound in Obstetrics and Gynecology, Vol. 12, No. 3, 28.10.1998, p. 156-162.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population

AU - Pajkrt, E.

AU - Mol, B. W J

AU - Van Lith, J. M M

AU - Bleker, O. P.

AU - Bilardo, C. M.

PY - 1998/10/28

Y1 - 1998/10/28

N2 - Objective. To examine the discriminative capacity of nuchal translucency measurement in the detection of trisomy 21 and other chromosomal anomalies. Design. Prospective cohort study. Subjects. A total of 2247 women with viable singleton pregnancies between 10 and 14 weeks' gestation attending a prenatal diagnosis center for fetal karyotyping. Methods. The fetal nuchal translucency was measured transabdominally in all women before invasive prenatal testing. Results. Chromosomal abnormalities were found in 63 fetuses, including 36 with Down's syndrome. The likelihood of the presence of chromosomal abnormalities increased with larger nuchal translucency thickness. A nuchal translucency of 3 mm or more identified 25 out of 36 fetuses (69%) with trisomy 21 at the expense of a 4.0% false-positive rate. Correction of nuchal translucency measurements for differences due to variation of the measurement with gestational age, either by using the 'delta-value' or multiples of the median (MoM), did not improve the detection rate in our patient data set. Conclusions. The discriminative capacity of nuchal translucency measurement makes is a useful tool in screening for trisomy 21 and other chromosomal anomalies.

AB - Objective. To examine the discriminative capacity of nuchal translucency measurement in the detection of trisomy 21 and other chromosomal anomalies. Design. Prospective cohort study. Subjects. A total of 2247 women with viable singleton pregnancies between 10 and 14 weeks' gestation attending a prenatal diagnosis center for fetal karyotyping. Methods. The fetal nuchal translucency was measured transabdominally in all women before invasive prenatal testing. Results. Chromosomal abnormalities were found in 63 fetuses, including 36 with Down's syndrome. The likelihood of the presence of chromosomal abnormalities increased with larger nuchal translucency thickness. A nuchal translucency of 3 mm or more identified 25 out of 36 fetuses (69%) with trisomy 21 at the expense of a 4.0% false-positive rate. Correction of nuchal translucency measurements for differences due to variation of the measurement with gestational age, either by using the 'delta-value' or multiples of the median (MoM), did not improve the detection rate in our patient data set. Conclusions. The discriminative capacity of nuchal translucency measurement makes is a useful tool in screening for trisomy 21 and other chromosomal anomalies.

KW - Down's syndrome

KW - Fetal aneuploidies

KW - Nuchal translucency

KW - Prenatal diagnosis

KW - Ultrasound screening

UR - http://www.scopus.com/inward/record.url?scp=0031663051&partnerID=8YFLogxK

U2 - 10.1046/j.1469-0705.1998.12030156.x

DO - 10.1046/j.1469-0705.1998.12030156.x

M3 - Article

VL - 12

SP - 156

EP - 162

JO - Ultrasound in Obstetrics and Gynecology

T2 - Ultrasound in Obstetrics and Gynecology

JF - Ultrasound in Obstetrics and Gynecology

SN - 0960-7692

IS - 3

ER -